08/05/2026
An Alzheimer's diagnosis often comes too late β after the window to plan, prepare, and access treatment has already started closing.
Our President & CEO, Jason Resendez, makes that case in The New York Times letter to the editor published today, responding to the paper's recent coverage of new blood-based testing for Alzheimer's disease.
New USC research cited in the letter found that family caregivers provide 6.8 billion hours of care each year to a relative or friend with dementia, valued at an estimated $237 billion. Data from the National Alliance for Caregiving and the Alzheimer's Association shows that family caregivers of people with Alzheimer's are nearly twice as likely as other caregivers to report that their own health has declined as a result of their caregiving duties.
"Reliable blood testing would give families something they rarely get now: time."
Time to access new treatments. Time to plan ahead. Time to protect their own health along the way.
Congress is already looking ahead, too. The bipartisan Alzheimer's Screening and Prevention (ASAP) Act would direct Medicare to cover routine blood-based screening once the FDA signs off β legislation Jason is calling on Congress to support.
π Read Jason Resendez's letter in The New York Times: https://www.nytimes.com/2026/08/02/opinion/alzheimers-test.html